A randomised clinical trial investigating the effect of fondaparinux versus no treatment in Patients with a nonsurgical fracture of the lower extremity immobilised in a below-knee plaster cast
Studied treatment | fondaparinux 2,5 mg daily group during immobilization |
Control treatment | no treatment |
3rd arm with nadroparin
Patients | Patients with a nonsurgical fracture of the lower extremity immobilised in a below-knee plaster cast |
Group sizes | -9 / -9 |
Inclusion criteria | at least 18 years; with a nonsurgical fracture of the lower extremity requiring immobilisation in a below-knee plaster cast for a minimum of 4 weeks; |
Type of immobilization. | |
Type of injury requiring immobilization. | |
Screening method |
Blindness | single blind | Inclusion period | |
Follow-up duration | Centers | ||
Lost to FU | geographical localisation | ||
Primary endpoint | deep vein trombosis as detected by venous duplex | Design | Parallel groups |
estimated enrollment n=669
ClinicalTrial.gov record NCT00881088
Appears in following systematic reviews: